doi:10.5578/tt.57403 Brenner R, Kivity S, Peker M, et al
Whichever direction you choose, understanding your options is the first step toward building a plan that fits your life
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports
Why it's GLP-1 friendly: One of the best protein-to-calorie ratios on my entire site
This combination may occasionally lead to urinating frequently and losing weight at the same time during treatment